Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia
- Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America.
- As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile.
- Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly strengthening its profitability.
Aachen, Germany, 2 June 2025 – Grünenthal today announced the acquisition of the commercial rights to Cialis® (tadalafil) in Mexico, Brazil and Colombia from Eli Lilly and Company. Over the next few years, Grünenthal and Lilly will work together to transfer the manufacturing to Grünenthal's production site in Santiago, Chile, that will supply Cialis® for Mexico, Brazil and Colombia moving forward. The transaction is expected to close in the third quarter of 2025, subject to the satisfaction of customary closing conditions. Grünenthal will finance the transaction using available liquidity. The financial terms of the transaction are not disclosed.
Cialis® is indicated for the oral treatment of erectile dysfunction and signs and symptoms of benign prostatic hyperplasia in adult men[1]. The acquisition will expand Grünenthal's Latin American Men's Health product portfolio.
"Executing on our strategy of targeted acquisitions, Cialis® will expand our existing portfolio in the region and strengthen Grünenthal's Latin American business", says Gabriel Baertschi, CEO, Grünenthal. "In 2022, we acquired Nebido®, a long-acting treatment for testosterone deficiency, and with Cialis® we can continue to serve our existing customer base and foster our growth in key Latin American markets."
Through the acquisition of Cialis®, Grünenthal continues executing its strategy of acquiring established medicines to expand its portfolio and increase its profitability. Since 2017, Grünenthal has invested over €2 billion in the acquisition of established medicines, including Nebido®, the European rights to Crestor® and Nexium®, as well as the global rights to Vimovo® (excluding the U.S. and Japan), Qutenza® and Zomig® (excluding Japan). In 2023, Grünenthal established Grünenthal Meds, a joint venture with Kyowa Kirin International, which manages a portfolio of 13 brands primarily focused on pain management and, in 2024, acquired the US company Valinor Pharma and the product Movantik®.
More information: www.grunenthal.com
Follow us on:
LinkedIn: Grunenthal Group
Instagram: grunenthal
[1] In Mexico Cialis® is indicated for the oral treatment of erectile dysfunction and symptoms of benign prostatic hyperplasia in adult men.
Nyckelord
Kontakter
For further information, please contact:
Maren Thurow
Head Global Communication
Grünenthal GmbH
52099 Aachen
E-Mail: Maren.Thurow@grunenthal.com
Phone: +44 7917 196855
About Grünenthal
Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Our products are available in approx. 100 countries. In 2024, Grünenthal employed around 4,300 people and achieved revenues of €1.8 billion.
Följ news aktuell GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från news aktuell GmbH
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:00:56 CET | Press Release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
MT Raceteam entering Ligier European Series with 16 year old Marcus Terkildsen / attractive partnerships and high visibility available18.12.2025 13:28:55 CET | Press Release
Copenhagen, Dec 18, 2025 - MT Raceteam is proud to announce its 2026 entry into the prestigious Ligier European Series, where the team will compete in a state-of-the-art Ligier JS2 R supplied by 23 Events Racing. This marks an important milestone for both the team and sixteen-year-old Danish driver Marcus Terkildsen as they step into one of Europe’s most competitive championships.
NTT DATA acquires The Cloud People to expand ServiceNow expertise and strengthen global reach18.12.2025 12:00:00 CET | Press Release
Bielefeld, Germany/Oslo, Norway — December 18, 2025 — NTT DATA announces the acquisition of The Cloud People Group AS, one of the largest pure-play ServiceNow partners in Europe. Founded in 2019, The Cloud People is headquartered in Oslo, Norway, with offices across northern Europe, the USA and Brazil, and will become part of NTT DATA Business Solutions, a business unit of NTT DATA. As a leading provider of ServiceNow solutions for medium and large enterprises, The Cloud People offer a focused value proposition covering the entire ServiceNow platform. The company delivers services across multiple workflows including IT service management, incident, problem and change management, automation of routine tasks, resource planning, onboarding and offboarding of employees, as well as customer service and security operations. The acquisition of The Cloud People will add 130 active customers to NTT DATA Business Solutions’ portfolio. The Cloud People is at the forefront of ServiceNow’s AI evolu
fulfillmenttools Delivers Global Order Management Solution for DEICHMANN18.12.2025 11:02:35 CET | Press Release
fulfillmenttools will support DEICHMANN in streamlining its order processing across different channels. The platform connects and manages the retailer’s inventory and order management across several countries, online shops, physical stores, and marketplaces. Partnering with Europe’s leading footwear retailer highlights fulfillmenttools’ strong position in Order Management and demonstrates the solution’s adaptability for international commerce.
ZEISS concludes fiscal year 2024/25 with solid growth18.12.2025 11:00:00 CET | Press Release
Revenue totaled almost 12 billion euros, with EBIT at 1.552 billion euros. The segments once again presented a mixed picture. Targeted resilience measures and investments in innovative strength are the key to the future. Mixed picture in all four segments Targeted resilience measures continued Expenditure on research and development still high at 15% of revenue Current outlook challenging
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.
Besök vårt pressrum